Approval · Notice of Compliance 18925 · 2017
ZELBORAF: Notice of Compliance 18925
Issued January 24, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18925
- Date
- January 24, 2017
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph with efficacy and safety results of a phase ii clinical trial in metastatic melanoma in patients with brain metastases
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZELBORAF | Not yet assigned | — |
Medicinal ingredients
- VEMURAFENIB 240 MG per TAB